Novo Nordisk gets obesity drug approved in Canada
The pharmaceutical company has received marketing authorization for Wegovy from Health Canada, it reports in a press release.
by christopher due karlsson, translated by catherine brett
The Canadian health agency, Health Canada, has approved Novo Nordisk's obesity drug Wegovy.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
